Literature DB >> 11222688

Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production.

C M Sharkey1, C L North, R J Kuhn, D A Sanders.   

Abstract

Pseudotyped retroviruses have important applications as vectors for gene transfer and gene therapy and as tools for the study of viral glycoprotein function. Recombinant Moloney murine leukemia virus (Mo-MuLV)-based retrovirus particles efficiently incorporate the glycoproteins of the alphavirus Ross River virus (RRV) and utilize them for entry into cells. Stable cell lines that produce the RRV glycoprotein-pseudotyped retroviruses for prolonged periods of time have been constructed. The pseudotyped viruses have a broadened host range, can be concentrated to high titer, and mediate stable transduction of genes into cells. The RRV glycoprotein-pseudotyped retroviruses and the cells that produce them have been employed to demonstrate that RRV glycoprotein-mediated viral entry occurs through endocytosis and that membrane fusion requires acidic pH. Alphavirus glycoprotein-pseudotyped retroviruses have significant advantages as reagents for the study of the biochemistry and prevention of alphavirus entry and as preferred vectors for stable gene transfer and gene therapy protocols.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222688      PMCID: PMC115889          DOI: 10.1128/JVI.75.6.2653-2659.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion.

Authors:  G M Taylor; D A Sanders
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  The Sindbis virus 6K protein can be detected in virions and is acylated with fatty acids.

Authors:  K Gaedigk-Nitschko; M J Schlesinger
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

3.  Location of a major antigenic site involved in Ross River virus neutralization.

Authors:  S Vrati; C A Fernon; L Dalgarno; R C Weir
Journal:  Virology       Date:  1988-02       Impact factor: 3.616

4.  A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

5.  The T=4 envelope of Sindbis virus is organized by interactions with a complementary T=3 capsid.

Authors:  S D Fuller
Journal:  Cell       Date:  1987-03-27       Impact factor: 41.582

6.  A safe packaging line for gene transfer: separating viral genes on two different plasmids.

Authors:  D Markowitz; S Goff; A Bank
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

7.  Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus.

Authors:  S Cassell; J Edwards; D T Brown
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

8.  Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.

Authors:  J R Sanes; J L Rubenstein; J F Nicolas
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

Review 9.  Virus entry into animal cells.

Authors:  M Marsh; A Helenius
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

10.  On the entry of Semliki forest virus into BHK-21 cells.

Authors:  A Helenius; J Kartenbeck; K Simons; E Fries
Journal:  J Cell Biol       Date:  1980-02       Impact factor: 10.539

View more
  17 in total

1.  Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins.

Authors:  Andrey A Kolokoltsov; Scott C Weaver; Robert A Davey
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 2.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

3.  Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting.

Authors:  Jean K Millet; Tiffany Tang; Lakshmi Nathan; Javier A Jaimes; Hung-Lun Hsu; Susan Daniel; Gary R Whittaker
Journal:  J Vis Exp       Date:  2019-03-01       Impact factor: 1.355

4.  Genome-wide RNAi screen identifies SEC61A and VCP as conserved regulators of Sindbis virus entry.

Authors:  Debasis Panda; Patrick P Rose; Sheri L Hanna; Beth Gold; Kaycie C Hopkins; Randolph B Lyde; Michael S Marks; Sara Cherry
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

5.  Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells.

Authors:  Blair L Strang; Yasuhiro Takeuchi; Thomas Relander; Johan Richter; Ranbir Bailey; David A Sanders; Mary K L Collins; Yasuhiro Ikeda
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Covalent modifications of the ebola virus glycoprotein.

Authors:  Scott A Jeffers; David Avram Sanders; Anthony Sanchez
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors.

Authors:  Kenneth P Greenberg; Scott F Geller; David V Schaffer; John G Flannery
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

8.  Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.

Authors:  Christoph A Kahl; Jon Marsh; Joanne Fyffe; David A Sanders; Kenneth Cornetta
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Functional pseudotyping of human immunodeficiency virus type 1 vectors by Western equine encephalitis virus envelope glycoprotein.

Authors:  Ananthalakshmi Poluri; Rebecca Ainsworth; Scott C Weaver; Richard E Sutton
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

10.  Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line.

Authors:  Naoki Inoue; Jörn Winter; Renu B Lal; Margaret K Offermann; Shin Koyano
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.